雪榕生物(300511) - 2024 Q3 - 季度财报

Revenue and Profit - Revenue for the third quarter was RMB 570.18 million, a slight increase of 0.27% year-over-year[2] - Net profit attributable to shareholders for the third quarter was a loss of RMB 20.22 million, an improvement of 88.05% compared to the same period last year[2] - Total operating income decreased to 1,641,052,971.34 from 1,943,485,303.98, a reduction of 15.56%[13] - Net profit attributable to the parent company decreased to -163,809,859.67 from -128,013,309.46, a further loss of 27.96%[14] - Comprehensive income for the period was -154,937,680.21 yuan, with a net loss attributable to the parent company of -163,533,452.43 yuan[15] - Basic and diluted earnings per share were both -0.33 yuan[15] Assets and Liabilities - Total assets decreased by 4.72% to RMB 4.38 billion compared to the end of the previous year[2] - Total current assets decreased to 640,085,164.96 from 766,596,581.22, a decline of 16.50%[12] - Total non-current assets decreased to 3,744,665,689.92 from 3,835,570,170.12, a reduction of 2.37%[12] - Total liabilities decreased to 3,101,625,409.37 from 3,169,782,736.69, a decline of 2.15%[13] - Total assets decreased to 4,384,750,854.88 from 4,602,166,751.34, a reduction of 4.72%[13] Debt and Financing - The company's short-term debt decreased by 49.09% to RMB 527.17 million due to repayment of short-term loans[5] - Long-term debt increased significantly by 178.11% to RMB 954.42 million due to new long-term loans[5] - Financing activities cash flow decreased by 83.36% to a net inflow of RMB 57.61 million due to increased debt repayments[7] - Cash flow from financing activities was 57,610,655.52 yuan, a significant decrease from 346,167,921.18 yuan in the previous period[17] R&D and Government Subsidies - R&D expenses decreased by 50.13% to RMB 2.99 million as some R&D projects were completed[6] - Government subsidies increased by 33.65% to RMB 8.69 million due to new subsidies for the Guigang project[6] Cash Flow and Liquidity - Investment activities cash flow improved by 40.91% to a net outflow of RMB 287.31 million due to reduced spending on fixed assets[7] - The company's monetary funds at the end of the period were 193,090,330.02 yuan, a decrease from 252,666,166.60 yuan at the beginning of the period[11] - The company's financial report indicates a significant decrease in monetary funds, reflecting potential liquidity challenges[11] - Cash flow from operating activities was 234,487,961.21 yuan, a decrease from 215,734,213.51 yuan in the previous period[17] - Cash flow from investing activities was -287,305,326.58 yuan, an improvement from -486,251,894.02 yuan in the previous period[17] - Net cash received from sales of goods and services was 1,634,316,700.65 yuan, a decrease from 1,940,851,008.13 yuan in the previous period[16] - Cash paid for goods and services was 953,529,925.75 yuan, a decrease from 1,230,116,809.46 yuan in the previous period[17] - Cash paid to employees was 410,592,920.32 yuan, a decrease from 435,113,691.44 yuan in the previous period[17] - Cash and cash equivalents at the end of the period were 166,322,970.01 yuan, an increase from 157,961,221.92 yuan at the beginning of the period[17] Shareholders and Equity - The total number of ordinary shareholders at the end of the reporting period is 33,731[8] - Yang Yongping holds 21.57% of the shares, totaling 107,606,850 shares, with 80,705,137 shares under restricted conditions[8] - Zhejiang Yinwan Private Fund Management Co., Ltd. holds 3.76% of the shares, totaling 18,734,600 shares[8] - Merrill Lynch International holds 0.50% of the shares, totaling 2,472,475 shares[8] - Barclays Bank PLC holds 0.45% of the shares, totaling 2,221,800 shares[8] - The total number of restricted shares at the end of the period is 80,772,074, with no changes during the period[9] - The company's restricted shares are primarily due to executive lock-up regulations, with Yang Yongping holding 80,705,137 restricted shares[9] Accounts Receivable and Inventory - Accounts receivable increased to 38,452,229.83 from 33,480,424.15, reflecting a growth of 14.85%[12] - Inventory decreased to 380,976,017.10 from 442,863,402.45, a reduction of 13.97%[12] Operating Costs and Expenses - Total operating costs decreased to 1,812,691,932.39 from 2,071,147,739.78, a decline of 12.48%[13] - Minority interest in net loss decreased to 8,484,242.62 from 1,302,661.82, an increase of 551.38%[14] Management and Corporate Governance - Yang Yongping, the company's chairman and general manager, was released from detention on October 20, 2024, and has resumed his duties[10] Audit and Reporting - The company's third-quarter report was not audited[18]